longevity
FOXO4-DRI tracker
Educational reference for FOXO4-DRI. Use it inside TrackPep to log doses, side effects, and rotation sites.
Half-life
—
Tmax
—
Category
longevity
Also known as: foxo4 d-retro-inverso
FOXO4-DRI is a preclinical senolytic peptide. No published human data.
Mechanism
A D-retro-inverso peptide designed to disrupt the interaction between FOXO4 and p53 in senescent cells.
Research summary
Studied in cell culture and mouse models of senescence. No human trials are published. Not approved for human use.
Educational summary of published research. Not dosing guidance or medical advice.
Sources
- Targeted apoptosis of senescent cells restores tissue homeostasis in response to chemotoxicity and aging · Cell (2017)Preclinical only; there is no published human PK.
TrackPep은 기록용 앱입니다. 사용자가 입력한 내용만 기록하며, 투여량을 추천하거나 계산하지 않습니다.